Skip to main content
. 2024 Apr 25;14:9497. doi: 10.1038/s41598-024-59713-0

Figure 1.

Figure 1

Distribution of FAM20C and FAM20A in control and RNS mutant gingivas. (A,D) In control gingiva, FAM20C immunoreactivity was found in large cytoplasmic vesicles of keratinocytes (A) and fibroblasts (D). (B,E) In RNS-1 gingiva, FAM20C immunoreactivity was localized around the nuclei of keratinocytes (arrow, (B)) and fibroblasts (arrow, (E)). Diffuse cytoplasmic immunoreactivity was also observed in some cells (arrowhead). (C,F) In RNS-2 gingiva, FAM20C was normally found in the cytoplasm of both keratinocytes (C) and fibroblasts (F), albeit with a weaker staining. (GI) FAM20A was expressed in the cytoplasm of fibroblasts of control (G) as well as RNS-1 (H) and RNS-2 (i) gingivas. (J) In GFs FAM20C expression (green) was found in the endoplasmic reticulum and at the interface with the cis-Golgi in HPA-positive (red) compartment (arrows). (K) In RNS-1 GFs, the staining was perinuclear. (L) In RNS-2 GFs, the staining was weaker and appeared in small cytoplasmic aggregates (arrowhead). (MO) Co-staining of control, RNS-1 and RNS-2 GFs with Concanavalin A. (M) Limited co-localization (arrow) of FAM20C (green) and the ER marker Concanavalin A in control GFs. (N) Extensive colocalization (arrow) of FAM20C and Concanavalin A in RNS-1 GFs. (O) Extensive colocalization (arrow) of FAM20C and Concanavalin A in RNS-2 GFs. Scale bars: (AI) = 30 μm; (JO) = 12 μm.